Please assess the completion status of the following clinical trial:

Trial Title: A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* male or female patients, \>=18 years of age;~* chronic renal anemia (Hb concentration 8.0g/dL - 10.0g/dL);~* no prior erythropoietin stimulating agent (ESA) therapy.~Exclusion Criteria:~* blood transfusion within the previous 4 weeks;~* poorly controlled hypertension;~* significant acute or chronic bleeding;~* active malignant disease;~* congestive heart failure (NYHA Class IV).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mircera (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).